Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Genetic Disruption of CCR5 Renders T Cells HIV Resistant
Link ID 7140
Title Genetic Disruption of CCR5 Renders T Cells HIV Resistant
Url http://www.medscape.com/viewarticle/576868?src=rss
Description The results of a mouse study provide proof of principle that a gene-editing approach using zinc finger nucleases can generate a population of HIV-resistant human T-cells similar to those in individuals who carry the natural CCR5-delta32 mutation. Reuters Health Information
Category Articles > HIV/AIDS
Keywords
Date Jul 1, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > HIV/AIDS
1. U.S. Care for HIV Detainees Falls Short: Report
  The U.S. Department of Homeland Security has failed to provide adequate care to immigrant detainees with HIV, putting their health and lives at risk, Human Rights Watch charged on Friday. Reuters Health Information
Category:   Articles > HIV/AIDS


2. Update on Epidemiologic Trends in HIV, Viral Hepatitis, and STDs
  Here Dr. Michael L. Tapper highlights the presentations from CROI 2008 regarding the epidemiology of HIV and changing patterns of HIV transmission as well as the epidemiology of hepatitis and STDs.
Category:   Articles > HIV/AIDS


3. New HIV Treatment Guidelines Issued
  New HIV treatment guidelines issued by the International AIDS Society–USA urge starting therapy sooner. Medscape Medical News
Category:   Articles > HIV/AIDS


4. HIV Treatment Access Increases, but Coverage Still Low
  As of the end of 2007, close to 3 million HIV-infected individuals in low- and middle-income nations had access to antiretroviral drug therapy (ART), representing an increase of nearly 950,000 people who received ART last year. Reuters Health Information
Category:   Articles > HIV/AIDS


5. HIV-Related Mortality Near Normal in First 5 Years on HAART
  In countries with good patient access to highly active antiretroviral therapy (HAART), persons infected with HIV currently experience mortality rates similar to that of the general population in the first 5 years after seroconversion, members of the CASCADE (Concerted Action on Seroconversion to AIDS and Death in Europe) collaboration report. Reuters Health Information
Category:   Articles > HIV/AIDS




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS